Therefore, we measured the sensitivities of BL cell lines to the pan-AKT inhibitor AZD5363 in comparison with pAKThigh GCB-DLBCL cell lines, which are highly sensitive to AZD5363 in vitro and in vivo [26]. Here, AKT1 is linked to diffuse large B-cell lymphoma.